Journal article
The steroid 5 alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women
AB Spurdle, JL Hopper, XQ Chen, GS Dite, MRE McCredie, GG Giles, DJ Venter, MC Southey, DM Purdie, G Chenevix-Trench
Cancer Epidemiology, Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2001
Grants
Awarded by NCI NIH HHS